The New York Metropolitan Transportation Authority (MTA) is proposing the expansion of sleep apnea screening and treatment to Long Island Rail Road train engineers and conductors, New York City Transit subway train operators and conductors, and bus operators for New York City Transit and the MTA Bus Company, becoming the first public transportation agency to systematically screen employees for obstructive sleep apnea and offer priority, specialized treatment to employees.
Pending the approval of the MTA Board on Wednesday, this program, which started at Metro-North Railroad in 2015, will expand to nearly 20,000 employees.
“Safety is our top priority and MTA is going further than any other transportation agency in the country to prevent the risks of apnea. With this proposal, we are not just working to implement industry best practices, the MTA is defining best practices,” said MTA Chairman and CEO Thomas F. Prendergast. “Sleep apnea is a serious illness and treatment will improve the quality of life for those who have it, and help them live longer.”
Sleep apnea is a medical disorder in which breathing repeatedly stops and starts while a person is sleeping, sometimes hundreds of times, when the patient’s throat muscles intermittently relax and block his or her windpipe. This results in insufficient sleep. Left untreated, someone with the disorder functions with reduced alertness and may involuntarily fall asleep.
Using a similar methodology to that already underway at Metro-North Railroad, sleep apnea screenings will include an evaluation of an employee’s Body Mass Index, neck circumference, a medical questionnaire related to sleep and sleep patterns, and relevant medical history. Employees who are deemed at risk based upon the screening will be referred for further testing and potential diagnosis and treatment.
Those referred for more detailed testing will be given a take-home overnight sleep test administered by a medical firm that specializes in sleep disorders. Based on the results, some employees may be required to undergo medical treatment for sleep apnea, which is generally treated through the use of masks that deliver continuous positive airway pressure, or oral devices that keep the airway open, either of which is worn at home during sleep.
The MTA has evaluated proposals from 13 healthcare companies who responded to a request for proposals issued last April.
METRO’s People Movement highlights the latest leadership changes, promotions, and personnel news across the public transit, motorcoach, and people mobility sectors.
BART began offering select parking lots to non-BART riders to generate new revenue to help address its FY27 $376M operating budget deficit brought on by remote work.
Drawing on decades of industry experience, Evans-Benson offered insights into the differences between the two, along with tips for better customer engagement and more.
The renewals include continued operations at Fort Lauderdale-Hollywood International Airport in Florida; the PRTC in Virginia; and RTC Washoe in Nevada.
The governor’s proposed auto insurance reforms could save the agency $48 million annually by limiting payouts in crashes where buses are not primarily at fault.
What truly drives the cost of a paratransit fleet? Beyond the purchase price, seven operational factors quietly determine maintenance frequency, downtime, and long-term service reliability. This whitepaper explores how these factors shape lifecycle cost and what agencies should evaluate when selecting paratransit vehicles.
In this conversation, TBC’s Executive Director Ed Redfern, President Corey Aldridge, and Washington Representative Joel Rubin outline the coalition’s key policy priorities, the challenges facing transit agencies, and how industry stakeholders can work together to strengthen the voice of bus transit at the federal level.
Amanda Wanke, who has worked at DART for 10 years, including the past 2½ years as CEO, will join Metro Transit as deputy chief operating officer, operations administration.
